Epstein-Barr Virus: Inhibition of Replication by Three New Drugs

Overview

Journal Science

Specialty Science

Date 1983 Aug 5

PMID 6306771

Citations 16

Authors

J C Lin

M C Smith

Y C Cheng

J S Pagano

Affiliations

Soon will be listed here.

Abstract

Epstein-Barr virus (EBV) is the cause of infectious mononucleosis and is associated with three human malignancies. Acyclovir [9-(2-hydroxyethoxymethyl)guanine], the first clinically useful drug effective against replication of EBV, is without effect against latent or persistent EBV infection. Three nucleoside analogs, E-5-(2-bromovinyl)-2'-deoxyuridine, 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine, and 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-methyluracil are potent inhibitors of EBV replication in vitro. Moreover, in contrast to the reversibility of viral inhibition by Acyclovir, these three drugs have prolonged effects in suppressing viral replication even after the drugs are removed from persistently infected cell cultures.

Citing Articles

Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.

Gruffaz M, Zhou S, Vasan K, Rushing T, Michael Q, Lu C mBio. 2018; 9(3).

PMID: 29739902 PMC: 5941074. DOI: 10.1128/mBio.00756-18.

Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships.

Lin J, Cherng J, Hung M, Baltina L, Baltina L, Kondratenko R Antiviral Res. 2008; 79(1):6-11.

PMID: 18423902 PMC: 7114209. DOI: 10.1016/j.antiviral.2008.01.160.

Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers.

Pegtel D, Middeldorp J, Thorley-Lawson D J Virol. 2004; 78(22):12613-24.

PMID: 15507648 PMC: 525079. DOI: 10.1128/JVI.78.22.12613-12624.2004.

Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole.

Zacny V, Gershburg E, Davis M, Biron K, Pagano J J Virol. 1999; 73(9):7271-7.

PMID: 10438815 PMC: 104252. DOI: 10.1128/JVI.73.9.7271-7277.1999.

In search of a selective antiviral chemotherapy.

De Clercq E Clin Microbiol Rev. 1997; 10(4):674-93.

PMID: 9336668 PMC: 172940. DOI: 10.1128/CMR.10.4.674.